Press centre

Latest

28 Oct 2019

GARDP unveils plans to deliver 5 BY 25 in collaboration with partners during World Health Summit

Today, the Global Antibiotic Research and Development Partnership (GARDP) unveiled its strategy to deliver five new treatments that address urgent drug-resistant infections by 2025.

5 Dec 2019

GARDP welcomes Germany’s commitment to tackling drug-resistant gonorrhoea

3 Dec 2019

GARDP announces Dr Mercedes Tatay as new Board member

30 Oct 2019

Dutch Ministry of Health, Welfare and Sport renews commitment to support GARDP

28 Oct 2019

UK government invests in global partnership to treat gonorrhoea

22 Oct 2019

GARDP selects Veronika von Messling as newest Board member and Prabhavathi Fernandes as Chair of the Scientific Advisory Committee

30 Sep 2019

GARDP and Entasis Therapeutics initiate global phase 3 trial of zoliflodacin, a first-in-class oral antibiotic for the treatment of gonorrhoea

Media contacts

For media inquiries, please contact the GARDP Communications Department:

Phone: +41 22 555 19 90 | Email: communications@gardp.org

Cookie Policy

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.